| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5536439 | Vaccine | 2017 | 7 Pages |
Abstract
In summary, effective protection against highly pathogenic H5N1 influenza virus was provided by both homologous H5N1 M2SR and heterologous H1N1 M2SR demonstrating the cross-protective attributes of the M2SR platform.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Yasuko Hatta, David Boltz, Sally Sarawar, Yoshihiro Kawaoka, Gabriele Neumann, Pamuk Bilsel,